Calais Philippe 4
4 · Transcode Therapeutics, Inc. · Filed May 19, 2023
Insider Transaction Report
Form 4
Calais Philippe
Director
Transactions
- Award
Stock Option (right to buy)
2023-05-19+45,000→ 45,000 totalExercise: $0.28Exp: 2033-05-18→ Common Stock (45,000 underlying)
Footnotes (1)
- [F1]The shares subject to this option shall vest and become exercisable in full on December 31, 2023, subject to the Reporting Person's continued service at such time.